Management of Patients With Acute Myocardial Infarction and Cardiogenic Shock.

We were interested to read the paper by Lemor et al. ([1][1]), which compared 198 patients from the NCSI (National Cardiogenic Shock Initiative) trial who were treated with either multivessel percutaneous coronary intervention (MV-PCI) or culprit-vessel PCI (CV-PCI) for acute myocardial infarction